ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41681997

Liquid Biopsy for Early Pancreatic Cancer Detection: Why Has It Not Yet Worked?

Takahashi K and 6 others. Cancers (Basel), 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Liquid Biopsy for Early Pancreatic Cancer Detection: Why Has It Not Yet Worked? Papers, record 41681997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41681997

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Liquid Biopsy for Early Pancreatic Cancer Detection: Why Has It Not Yet Worked?
PubMed
Journal
Cancers (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-02-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Takahashi KKenjihttps://orcid.org/0000-0002-6166-6848
2Ono YYusukehttps://orcid.org/0000-0001-8385-5386
3Taniue KKenzuihttps://orcid.org/0000-0003-3660-3009
4Patra KCKrushna C
5Yamamoto TTakuyahttps://orcid.org/0000-0003-3753-1211
6Fujiya MMikihiro
7Mizukami YYusukehttps://orcid.org/0000-0002-1068-7024

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
KAKENHI [Grant Numbers: 24K11058 (to KenjiT)]The Japan Society for the Promotion of Science (JSPS)PubMed
The Suzuken Memorial Foundation 2025The Suzuken Memorial FoundationPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,244,341CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer.Oncology2022https://conductscience.org/library/papers/36244341PubMed
240,129,923Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosis.Front Oncol2025https://conductscience.org/library/papers/40129923PubMed
335,102,279Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.Nat Biomed Eng2022https://conductscience.org/library/papers/35102279PubMed
428,984,789S100P in Duodenal Fluid Is a Useful Diagnostic Marker for Pancreatic Ductal Adenocarcinoma.Pancreas2017https://conductscience.org/library/papers/28984789PubMed
524,493,213Long noncoding RNA in liver diseases.Hepatology2014https://conductscience.org/library/papers/24493213PubMed
628,419,195Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients.Ann Oncol2017https://conductscience.org/library/papers/28419195PubMed
737,470,859Current status of molecular diagnostic approaches using liquid biopsy.J Gastroenterol2023https://conductscience.org/library/papers/37470859PubMed
839,902,566KRAS Mutations in Duodenal Lavage Fluid After Secretin Stimulation for Detection of Pancreatic Cancer.Ann Surg2026https://conductscience.org/library/papers/39902566PubMed
939,764,541A noninvasive urinary microRNA-based assay for the detection of pancreatic cancer from early to late stages: a case control study.EClinicalMedicine2024https://conductscience.org/library/papers/39764541PubMed
1016,288,055Possible detection of pancreatic cancer by plasma protein profiling.Cancer Res2005https://conductscience.org/library/papers/16288055PubMed

1 to 10 of 70

See all 70 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42,921,021Liquid biopsy in pancreatic ductal adenocarcinoma from diagnostic accuracy to clinical utility.Front Oncol2026https://conductscience.org/library/papers/42921021PubMed
42,638,133Multidimensional 5-hydroxymethylcytosine features in cell-free DNA enable the detection, staging and subtyping of pancreatic ductal adenocarcinoma.Biomark Res2026https://conductscience.org/library/papers/42638133PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41681997

GET https://conductscience.org/api/papers/v1/41681997/references?page=2

API referenceFor AI assistants